|
|
Blood, 1 September 2008, Vol. 112, No. 5, pp. 1784-1793.
Prepublished online as a Blood First Edition Paper on June 25, 2008; DOI 10.1182/blood-2008-02-142745.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
STAT3 is required for IL-21–induced secretion of IgE from human naive B cells
Danielle T. Avery1,
Cindy S. Ma1,
Vanessa L. Bryant1,
Brigitte Santner-Nanan2,
Ralph Nanan2,
Melanie Wong3,
David A. Fulcher4,
Matthew C. Cook5, and
Stuart G. Tangye1
1 Immunology and Inflammation Group, Garvan Institute of Medical Research, Darlinghurst;
2 Discipline of Paediatrics, Nepean Clinical School, University of Sydney, Penrith;
3 Department of Immunology and Allergy, Children's Hospital, Westmead;
4 Immunology Unit, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead; and
5 Department of Immunology, Canberra Hospital, Woden, Australia
The production of immunoglobulin E (IgE) is tightly regulated. This is evidenced by the fact that it comprises less than 0.0001% of serum Ig, and aberrant production causes atopic conditions, including allergy, rhinitis, and anaphylaxis. Interleukin-4 (IL-4) is a well-characterized inducer of IgE by human and murine B cells, whereas interferon- can antagonize this effect. IL-21 has also been recognized for its ability to suppress IL-4–induced IgE production by murine B cells. Here, we identified IL-21 as an inducer of IgE production by CD40L-stimulated human naive B cells. Furthermore, there was a striking synergy between IL-4 and IL-21 on inducing IgE secretion by CD40L-stimulated human B cells, such that the levels detected under these conditions exceeded those induced by IL-4 or IL-21 alone by more than 10-fold. IL-21 induced activation of STAT3 and analysis of B cells from patients with loss-of-function STAT3 mutations revealed that the ability of IL-21 to induce IgE secretion, and augment that driven by IL-4, was STAT3-dependent. These findings highlight a fundamental difference between the regulation of IgE production by human and murine B cells and have implications for the dysregulated production of IgE in conditions characterized by extremely high levels of serum IgE.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Heine, A. Dahten, K. Hilt, D. Ernst, M. Milovanovic, B. Hartmann, and M. Worm
Liver X Receptors Control IgE Expression in B Cells
J. Immunol.,
May 1, 2009;
182(9):
5276 - 5282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Minegishi and H. Karasuyama
Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency
Int. Immunol.,
February 1, 2009;
21(2):
105 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Tangye, M. C. Cook, and D. A. Fulcher
Insights into the Role of STAT3 in Human Lymphocyte Differentiation as Revealed by the Hyper-IgE Syndrome
J. Immunol.,
January 1, 2009;
182(1):
21 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|